Lion stock went into this earnings print with a strong recent run, up about 16.6% over three months and closing at ¥1,797.5 just as the results hit. The headline is simple: profit growth is doing the heavy lifting behind that optimism.
Q2 basic earnings per share came in at ¥23.99 on revenue of ¥117,631m. Over the last twelve months basic earnings per share reached ¥104.14 and net income from ongoing operations was ¥28,822m. For a consumer products group where small margin moves matter, that profit engine is the number investors are reacting to.
Is Lion a genuine bargain or just cheap for a reason given its 51.9% gap to the DCF estimate and mixed growth outlook? Compare the market price to the detailed valuation analysis for Lion
Q2 2026 Earnings Summary
- Revenue Q2 2026: ¥117,631m vs. Q2 2025 ¥105,222m (higher year on year)
- Net Income Q2 2026 (Excl. Extra Items): ¥6,638m vs. Q2 2025 ¥5,583m (higher year on year)
- Basic EPS Q2 2026: ¥23.99 per share vs. Q2 2025 ¥20.21 per share (higher year on year)
- Trailing Net Profit Margin (Last 12 Months): 6.6% vs. 12 months earlier 5.0% (margin improved)
Prefer clean charts instead of scrolling through paragraph after paragraph of earnings commentary and spreadsheets? Get a full visual view of Lion’s valuation story in the company report for Lion.
Lion bullish story: margin shift gets a reality check
Bulls argue Lion is turning into a higher margin Oral Health Care and premium personal care group, with profit structure reforms and digital tools doing the heavy lifting. The latest numbers partly support that. Revenue reached ¥117,631m in Q2 2026 and net income from ongoing operations over the last twelve months was ¥28,822m. Trailing net profit margin sits at 6.6%, compared with 5.0% a year earlier, which is consistent with a mix and efficiency story that is starting to work. Basic EPS of ¥23.99 in Q2 and ¥104.14 over twelve months backs the idea that earnings are doing more of the work than just sales volume. What this set does not yet prove is how much of the uplift comes from Oral Health Care, premiumisation, or digital programs versus simpler levers such as pricing and cost control.
Bear case on Lion: overseas and execution risks still matter
Bears worry that reliance on overseas growth, portfolio reshaping and cost savings could backfire, leaving Lion with pressured margins and patchy earnings. This quarter does not confirm that worst case. Net income excluding extra items was ¥6,638m in Q2 2026 compared with ¥5,583m a year earlier and the trailing margin is higher at 6.6%. That points to cost and mix actions not yet eroding profitability. At the same time, the 51.9% gap to the DCF estimate and comments about “mixed growth outlook” show that uncertainty around the long term path remains. The portfolio shift and expansion in Southeast Asia, South Asia and China are still in execution mode. Any stumble on product rationalisation, consumer response or overseas regulation could quickly test whether this profit level is durable.
Compare Lion’s margin story and overseas execution against what institutional analysts are pricing in at ¥1,797.5. See the consensus price target analysis for Lion to check how far Street targets sit from where the stock closed after these results.Stay Ahead With Lion And Simply Wall St
If Lion’s widening profit margin and the 51.9% gap to the DCF estimate have your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and monitor any changes over time. After you take a position, keep your decisions clear with the Portfolio Command Center that highlights key developments on Lion and your other holdings without overwhelming you with information. For a broader view on what other investors are thinking, use the Community and see how different perspectives compare with your own analysis. By identifying possible catalysts and risks early, you may be able to stay more informed about developments in the market.
Seeking Alternatives Beyond Lion Stock?
Fresh stock ideas can move from quiet potential to full breakout before most investors notice. Use these under the radar for now screeners while it matters and get in early.
- Spot cash rich companies that may have been overlooked by the crowd and review the curated list of solid balance sheet and fundamentals stocks (40 results) before momentum really starts to build.
- Ride structural shifts in energy and infrastructure by scanning the hand picked 89 nuclear energy infrastructure stocks while many investors are still watching yesterday’s themes.
- Target strong payout opportunities with staying power by checking the focused 43 dividend fortresses before yields compress and the most attractive entry points start dropping out of reach.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com